|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Concert Pharmaceuticals, Inc. (CNCE) |
|
|
$8.37 0.00 (0.00%) as of 4:30 Fri 3/3
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,940,000 |
Market
Cap: |
401.26(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$8.37 - $8.37 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Concert Pharmaceuticals is a late-stage clinical biopharmaceutical company that is developing CTP-543, a Janus Kinase 1 and Janus Kinase 2 inhibitor that Co. discovered through the application of its DCE Platform® (deuterated chemical entity platform). Co. is evaluating CTP-543 in a Phase 3 clinical program for the treatment of alopecia areata, a serious autoimmune dermatological condition. In addition to its wholly-owned development programs, Co. has entered into collaborative arrangements with companies to develop deuterium-modified versions of their marketed products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
81,977 |
Total Sell Value |
$0 |
$0 |
$0 |
$653,253 |
Total People Sold |
0 |
0 |
0 |
6 |
Total Sell Transactions |
0 |
0 |
0 |
14 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Aldrich Richard |
Director |
|
2018-01-16 |
4 |
AS |
$19.26 |
$192,650 |
I/I |
(10,000) |
77,405 |
|
- |
|
Aldrich Richard |
Director |
|
2018-01-16 |
4 |
AS |
$19.08 |
$405,183 |
D/D |
(21,236) |
286,975 |
|
- |
|
Aldrich Richard |
Director |
|
2018-01-16 |
4 |
OE |
$2.88 |
$77,405 |
D/D |
21,236 |
308,211 |
|
- |
|
Lampert Mark N |
10% Owner |
|
2017-12-19 |
4 |
S |
$26.65 |
$34,188,112 |
D/D |
(1,282,856) |
122,496 |
|
- |
|
Barrett Ronald W |
Director |
|
2017-12-04 |
4 |
S |
$24.70 |
$349,653 |
D/D |
(14,156) |
0 |
|
- |
|
Barrett Ronald W |
Director |
|
2017-12-04 |
4 |
OE |
$2.88 |
$51,599 |
D/D |
14,156 |
14,156 |
|
- |
|
Tung Roger D |
Chief Executive Officer |
|
2017-11-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,600 |
623,098 |
|
- |
|
Tung Roger D |
Chief Executive Officer |
|
2017-11-17 |
4 |
D |
$20.91 |
$33,602 |
D/D |
(1,607) |
624,698 |
|
- |
|
Tung Roger D |
Chief Executive Officer |
|
2017-11-17 |
4 |
OE |
$4.58 |
$33,617 |
D/D |
7,340 |
626,305 |
|
- |
|
Stuart Nancy |
Chief Operating Officer |
|
2017-11-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,100 |
102,978 |
|
- |
|
Stuart Nancy |
Chief Operating Officer |
|
2017-11-14 |
4 |
D |
$18.57 |
$19,294 |
D/D |
(1,039) |
104,078 |
|
- |
|
Stuart Nancy |
Chief Operating Officer |
|
2017-11-14 |
4 |
OE |
$4.58 |
$19,305 |
D/D |
4,215 |
105,117 |
|
- |
|
Lampert Mark N |
10% Owner |
|
2017-10-19 |
4 |
B |
$15.84 |
$5,256,720 |
D/D |
331,916 |
291,788 |
2.45 |
- |
|
Lynch Ryan |
PFO, PAO |
|
2017-09-14 |
4 |
S |
$14.51 |
$50,785 |
D/D |
(3,500) |
6,000 |
|
- |
|
Lynch Ryan |
PFO, PAO |
|
2017-09-14 |
4 |
OE |
$9.46 |
$33,110 |
D/D |
3,500 |
9,500 |
|
- |
|
Lynch Ryan |
PFO, PAO |
|
2017-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
|
- |
|
Stuart Nancy |
Chief Operating Officer |
|
2017-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
100,902 |
|
- |
|
Cassella James V |
Chief Development Officer |
|
2017-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
60,000 |
|
- |
|
Tung Roger D |
Chief Executive Officer |
|
2017-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
618,965 |
|
- |
|
Herscha Lynette |
General Counsel |
|
2017-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
Silverman Robert |
Senior VP, General Counsel |
|
2017-03-09 |
4 |
D |
$16.86 |
$34,968 |
D/D |
(2,074) |
50,307 |
|
- |
|
Silverman Robert |
Senior VP, General Counsel |
|
2017-03-09 |
4 |
OE |
$1.13 |
$34,992 |
D/D |
30,966 |
51,075 |
|
- |
|
Stuart Nancy |
Chief Operating Officer |
|
2017-03-08 |
4 |
D |
$16.04 |
$2,358 |
D/D |
(147) |
40,902 |
|
- |
|
Stuart Nancy |
Chief Operating Officer |
|
2017-03-08 |
4 |
OE |
$1.13 |
$2,371 |
D/D |
2,098 |
41,049 |
|
- |
|
Stuart Nancy |
Chief Operating Officer |
|
2016-12-06 |
4 |
D |
$8.94 |
$8,019 |
D/D |
(897) |
38,951 |
|
- |
|
238 Records found
|
|
Page 7 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|